Actinium Pharmaceuticals (ATNM) Corporate Presentation from NobleCon18News and Market Data on Actinium PharmaceuticalsNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


8/22/2025
Tech
Trump Moves to Take 10% Stake in Intel as U.S. Seeks Semiconductor Edge
The Biden-era CHIPS Act was designed to revive America’s semiconductor sector, but under the Trump administration, that funding is taking a new form: direct equity ownership. On Friday, President Trump...
3 min read
‌


8/22/2025
Healthcare
SelectQuote (SLQT) – Pharmacy Strength Highlights Revenue Stability
Fiscal Q4 beat. SelectQuote posted Q4 revenue of $345.1 million and adj. EBITDA of $2.7 million, beating expectations. Agent productivity improved with AI integration and workflow streamlining. The company navigated Medicare...
2 min read
‌


8/22/2025
Basic Materials
Nicola Mining Inc. (HUSIF) – Pivoting to Revenue and Cash Flow Growth
Accelerated warrant exercise. Nicola Mining Inc. (TSX.V: NIM, OTCQB: HUSIF, FSE: HLIA) reported the accelerated exercise of 2,019,477 share purchase warrants at C$0.40 each, generating C$807,791 in gross proceeds. On July 21,...
2 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.